BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26153072)

  • 1. Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement.
    Miyata Y; Sakai H
    Int J Urol; 2015 Sep; 22(9):806-15. PubMed ID: 26153072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement.
    Taverna G; Cote R; Grizzi F
    Int J Urol; 2016 Jan; 23(1):105. PubMed ID: 26354672
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to Re: Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement.
    Miyata Y; Sakai H
    Int J Urol; 2016 Jan; 23(1):105-6. PubMed ID: 26500042
    [No Abstract]   [Full Text] [Related]  

  • 4. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.
    Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P
    Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
    Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
    Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis in superficial esophageal squamous cell carcinoma: assessment of microvessel density based on immunostaining for CD34 and CD105.
    Kumagai Y; Sobajima J; Higashi M; Ishiguro T; Fukuchi M; Ishibashi K; Baba H; Mochiki E; Yakabi K; Kawano T; Tamaru J; Ishida H
    Jpn J Clin Oncol; 2014 Jun; 44(6):526-33. PubMed ID: 24748644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
    Behrem S; Zarkovic K; Eskinja N; Jonjic N
    Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvessel density assessment in benign and malignant endometrial changes.
    Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
    J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.
    Medetoglu B; Gunluoglu MZ; Demir A; Melek H; Buyukpinarbasili N; Fener N; Dincer SI
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):996-1000. PubMed ID: 20708755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
    Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
    Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays.
    Tretiakova M; Antic T; Binder D; Kocherginsky M; Liao C; Taxy JB; Oto A
    Hum Pathol; 2013 Apr; 44(4):495-502. PubMed ID: 23069258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic significance of microvessel density in ovarian cancer].
    Rossochacka-Rostalska B; Gisterek IJ; Suder E; Szelachowska JK; Matkowski RA; Lacko A; Kornafel JA
    Wiad Lek; 2007; 60(3-4):129-37. PubMed ID: 17726864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.
    Ratajczak P; Leboeuf C; Wang L; Brière J; Loisel-Ferreira I; Thiéblemont C; Zhao WL; Janin A
    Mod Pathol; 2012 Jun; 25(6):805-14. PubMed ID: 22322190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
    Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
    Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis.
    Cheng SH; Liu JM; Liu QY; Luo DY; Liao BH; Li H; Wang KJ
    Int J Clin Exp Pathol; 2014; 7(9):5855-63. PubMed ID: 25337227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
    Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
    Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin (CD105) positive microvessel density and its relationship with lymph node metastasis in squamous cell carcinoma of the tongue.
    Eshghyar N; Mohammadi N; Rahrotaban S; Motahhary P; Vahedi Vaez SM
    Arch Iran Med; 2011 Jul; 14(4):276-80. PubMed ID: 21726105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation.
    Trojan L; Thomas D; Friedrich D; Grobholz R; Knoll T; Alken P; Michel MS
    Anticancer Res; 2004; 24(3a):1651-6. PubMed ID: 15274336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of intratumoral microvessel density quantification based on immunohistochemical detection of PECAM-1 and vWF in colorectal carcinoma from Iraqi patients.
    Ahmed MM; Mohammed SH
    Indian J Pathol Microbiol; 2010; 53(3):439-46. PubMed ID: 20699499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma.
    Yamamoto A; Dhar DK; El-Assal ON; Igarashi M; Tabara H; Nagasue N
    J Hepatol; 1998 Aug; 29(2):290-9. PubMed ID: 9722211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.